Phase 2 study, led by Dr. Antonio Jimeno at the University of Colorado Anschutz Medical Campus will evaluate NT219 in ...

Cancer treatment times are being tackled in south Essex in a bid to provide "highest possible quality of care" after alarming new ...

CHANCES ARE, ONE out of five of you reading this will be diagnosed with skin cancer by the time you hit age 70. As the most ...

Douglas Adkins, MD, discusses future directions of the KEYNOTE-689 trial of pembrolizumab in head and neck cancer following the agent's FDA approval.

Smoking, alcohol consumption and betel nut chewing are some of the lifestyle factors that have been linked to head and neck ...

MSD has received US Food and Drug Administration (FDA) approval for its anti-programmed death receptor-1 (PD-1) therapy, ...

A Lampeter cancer nurse and international bowler has been named in the King's Birthday Honours List. Anwen Butten, a Head and ...

RaySearch Laboratories AB (publ) is pleased to announce that RayStation®*, its advanced treatment planning system, was used in the first European clinical treatments with Neutron Therapeutics' ...

Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the ...

A nurse was awarded an MBE in the 2025 King’s Birthday Honours because of her ‘truly inspiring’ work with patients.

"After my cancer diagnosis, I knew the initial assessment had missed everything. " Courtney Liniewski told Newsweek.

There are a number of things to look out for, but many of them often go ignored, according to leading oncologist Dr Jiri ...